This invention is not done and character being converted making use of the monoclonal antibody (AcMo) or the poly clonal antibody, regards the method of measuring the activation of the ehuekuta cell which belongs to the immunity system where also the te is good. This invention in the reaction nutrient medium features that it consists of the fact that at least one which is produced the antigen of the CD16 receptor revelation cell, and the (ii) said antibody, due to especially, and the CD16 receptor revelation cell which are made to contact sight Cain's quantity is measured under existing of the (i) antibody. In addition as for this invention, the autoimmune disease and the inflammation disease, it regards also the selection of the antibody which sight Cain like IFN or IL2 which is intended for remedying the infection symptom with the cancer, and the pathogenic agent and inducing the revelation of interleukin can do.
展开▼
